<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Composite <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (CLs) have been reported in 1-4.7% of <z:hpo ids='HP_0000001'>all</z:hpo> <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, however, CLs containing both T- and B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (CTBLs) are very rare </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we examined the clinical and pathological features of 29 CTBLs </plain></SENT>
<SENT sid="2" pm="."><plain>These CTBLs included 21 patients with angioimmunoblastic T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (AITL) and diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>), two with adult T-cell <z:hpo ids='HP_0001909'>leukemia</z:hpo>/<z:hpo ids='HP_0002665'>lymphoma</z:hpo> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>, one with AITL and Follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, one with <z:e sem="disease" ids="C1621719" disease_type="Neoplastic Process" abbrv="">Lennert</z:e> <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>, one with subcutaneous <z:mp ids='MP_0011164'>panniculitis</z:mp>-like T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>, one with peripheral T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTCL</z:e>) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>, one with cutaneous T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>, and one with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTCL</z:e> and <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Eighteen of 27 patients (67%) were shown to be Epstein-Barr virus (EBV)-encoded <z:chebi fb="40" ids="33697">RNA</z:chebi>-positive in their B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> component </plain></SENT>
<SENT sid="4" pm="."><plain>T-cell and B-cell clonality were confirmed by flow cytometry, Southern blot analysis, and/or polymerase chain reaction (PCR) </plain></SENT>
<SENT sid="5" pm="."><plain>Using Southern blot analysis, clonal immunoglobulin heavy chain (IgH) and T-cell receptor (TCR) rearrangements were detected in 11 of 21 and 15 of 24 cases, respectively </plain></SENT>
<SENT sid="6" pm="."><plain>Using PCR analysis, clonal IgH and TCR rearrangements were detected in 7 of 8 and 7 of 7 Southern blot-negative cases, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>Our results suggested that PCR analysis was useful in diagnosing CTBL </plain></SENT>
</text></document>